Endoscopy 2020; 52(S 01): S196
DOI: 10.1055/s-0040-1704611
ESGE Days 2020 ePoster Podium presentations
Friday, April 24, 2020 15:30 – 16:00 Upper GI: Endoscopic suturing ePoster Podium 1
© Georg Thieme Verlag KG Stuttgart · New York

ENDOSCOPIC SLEEVE GASTROPLASTY USING THE ENDOMINA DEVICE

N Musquer
1   University Hospital of Nantes, Digestive Diseases Institute, Nantes, France
,
E Coron
1   University Hospital of Nantes, Digestive Diseases Institute, Nantes, France
,
M Barthet
2   North Hospital, Assistance Publique - Hôpitaux de Marseille and University of Aix-Marseille, Marseille, France
› Author Affiliations
Further Information

Publication History

Publication Date:
23 April 2020 (online)

 

Endoscopic sleeve gastroplasty (ESG), is one of the promising endoscopic restrictive procedures aiming at tending towards the results of bariatric surgery while minimizing the risk of complications.

This short video presents the different steps of ESG. The patient didn’t experience major complication. At 1 month, 10.7% of total weight and 37.7% excess weight were lost. At 3 months, Total weight loss and total excess weight loss were 18,6% and 65,6% respectively, accompanied by improvement of quality of life scores, glycated hemoglobin and lipid status.

ESG seems to be an efficient and safe endoscopic alternative to bariatric surgery.